Saturday, February 8, 2025
spot_imgspot_img

Top 5 This Week

spot_imgspot_img

Related Posts

DVIDS News: Datlof Plans for Future of Military Medical Technology Transfer Following DOD Award


The Office of Medical Technology Transfer at Fort Detrick, Maryland, has been recognized for its success in commercializing innovative life-saving devices and medicines for the Warfighter and the public. Chief of business development and commercialization, Barry Datlof, recently received the 2024 Department of Defense George F. Linsteadt Technology Transfer Achievement Award for his contributions to the Assistive Technology Transfer (AT2) program. AT2 is a process that systematically matures and de-risks first-generation biomedical technologies.

The MTT team has successfully licensed over 30 biomedical technologies using AT2, generating over $26 million in royalty income. This revenue is reinvested back into the program to help move other new inventions through the development cycle, creating a feedback loop of success. AT2 connects inventors with expert assistance at each stage of development, ensuring that new technologies are mature and ready for manufacture.

Datlof emphasizes the collaborative and innovative approach of the MTT team, where risk-taking and creativity are encouraged. Looking ahead, Datlof proposes the establishment of a DOD-wide “angel fund” to speed up the adoption of AT2 at smaller tech transfer offices. Additionally, he envisions leveraging digital marketplace technologies to accelerate technology transfer and expanding international patent portfolios to increase income streams.

The success of the MTT team is attributed to their collective efforts, with Datlof recognizing the accomplishments of the entire team. As they embark on the next 25 years of medical technology transfer, the team is focused on further innovation and collaboration to continue saving lives and supporting the Warfighter’s mission.

Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles